The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Geographic Atrophy Treatment Market Research Report 2025
Synopsis
Market Analysis and Insights: Global Geographic Atrophy Treatment Market
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
The global Geographic Atrophy Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Late-stage (Phase III) Treatment accounting for % of the Geographic Atrophy Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Geographic Atrophy Treatment market size is valued at US$ million in 2021, while the North America and Europe Geographic Atrophy Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geographic Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geographic Atrophy Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geographic Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geographic Atrophy Treatment market.
Global Geographic Atrophy Treatment Scope and Market Size
Geographic Atrophy Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Geographic Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Market Analysis and Insights: Global Geographic Atrophy Treatment Market
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
The global Geographic Atrophy Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Late-stage (Phase III) Treatment accounting for % of the Geographic Atrophy Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Geographic Atrophy Treatment market size is valued at US$ million in 2021, while the North America and Europe Geographic Atrophy Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geographic Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geographic Atrophy Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geographic Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geographic Atrophy Treatment market.
Global Geographic Atrophy Treatment Scope and Market Size
Geographic Atrophy Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Geographic Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Late-stage (Phase III) Treatment
1.2.3 Phase II Treatment
1.2.4 Phase I Treatment
1.2.5 Pre-Clinical Stage Treatment
1.3 Market by Application
1.3.1 Global Geographic Atrophy Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Treatment Market Perspective (2017-2028)
2.2 Geographic Atrophy Treatment Growth Trends by Region
2.2.1 Geographic Atrophy Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2017-2022)
2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2023-2028)
2.3 Geographic Atrophy Treatment Market Dynamics
2.3.1 Geographic Atrophy Treatment Industry Trends
2.3.2 Geographic Atrophy Treatment Market Drivers
2.3.3 Geographic Atrophy Treatment Market Challenges
2.3.4 Geographic Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Treatment Players by Revenue
3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2017-2022)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Treatment Revenue
3.4 Global Geographic Atrophy Treatment Market Concentration Ratio
3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2021
3.5 Geographic Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Treatment Breakdown Data by Type
4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2017-2022)
4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2023-2028)
5 Geographic Atrophy Treatment Breakdown Data by Application
5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2017-2022)
5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Geographic Atrophy Treatment Market Size (2017-2028)
6.2 North America Geographic Atrophy Treatment Market Size by Country (2017-2022)
6.3 North America Geographic Atrophy Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Geographic Atrophy Treatment Market Size (2017-2028)
7.2 Europe Geographic Atrophy Treatment Market Size by Country (2017-2022)
7.3 Europe Geographic Atrophy Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2017-2028)
8.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Treatment Market Size (2017-2028)
9.2 Latin America Geographic Atrophy Treatment Market Size by Country (2017-2022)
9.3 Latin America Geographic Atrophy Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2017-2028)
10.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Detail
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.1.5 Apellis Pharmaceuticals Recent Development
11.2 IVERIC bio
11.2.1 IVERIC bio Company Detail
11.2.2 IVERIC bio Business Overview
11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction
11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.2.5 IVERIC bio Recent Development
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Detail
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.3.5 Alkeus Pharmaceuticals Recent Development
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Detail
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.4.5 Hemera Biosciences Recent Development
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Detail
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.5.5 Allegro Ophthalmics Recent Development
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Detail
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.6.5 Stealth BioTherapeutics Recent Development
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Detail
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.7.5 Gyroscope Therapeutics Recent Development
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Detail
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.8.5 Regenerative Patch Technologies Recent Development
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Detail
11.9.2 Roche Holding AG Business Overview
11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction
11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.9.5 Roche Holding AG Recent Development
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Detail
11.10.2 Gensight Biologics SA Business Overview
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction
11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.10.5 Gensight Biologics SA Recent Development
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Detail
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.11.5 NGM Biopharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.12.5 AstraZeneca Recent Development
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Detail
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.13.5 Lineage Cell Therapeutics Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Treatment Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.14.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Geographic Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Late-stage (Phase III) Treatment
Table 3. Key Players of Phase II Treatment
Table 4. Key Players of Phase I Treatment
Table 5. Key Players of Pre-Clinical Stage Treatment
Table 6. Global Geographic Atrophy Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Geographic Atrophy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Geographic Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Geographic Atrophy Treatment Market Share by Region (2017-2022)
Table 10. Global Geographic Atrophy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Geographic Atrophy Treatment Market Share by Region (2023-2028)
Table 12. Geographic Atrophy Treatment Market Trends
Table 13. Geographic Atrophy Treatment Market Drivers
Table 14. Geographic Atrophy Treatment Market Challenges
Table 15. Geographic Atrophy Treatment Market Restraints
Table 16. Global Geographic Atrophy Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Geographic Atrophy Treatment Market Share by Players (2017-2022)
Table 18. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2021)
Table 19. Ranking of Global Top Geographic Atrophy Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Geographic Atrophy Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Geographic Atrophy Treatment Product Solution and Service
Table 23. Date of Enter into Geographic Atrophy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Geographic Atrophy Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Geographic Atrophy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Geographic Atrophy Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Geographic Atrophy Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Geographic Atrophy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Geographic Atrophy Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Apellis Pharmaceuticals Company Detail
Table 44. Apellis Pharmaceuticals Business Overview
Table 45. Apellis Pharmaceuticals Geographic Atrophy Treatment Product
Table 46. Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 47. Apellis Pharmaceuticals Recent Development
Table 48. IVERIC bio Company Detail
Table 49. IVERIC bio Business Overview
Table 50. IVERIC bio Geographic Atrophy Treatment Product
Table 51. IVERIC bio Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 52. IVERIC bio Recent Development
Table 53. Alkeus Pharmaceuticals Company Detail
Table 54. Alkeus Pharmaceuticals Business Overview
Table 55. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product
Table 56. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 57. Alkeus Pharmaceuticals Recent Development
Table 58. Hemera Biosciences Company Detail
Table 59. Hemera Biosciences Business Overview
Table 60. Hemera Biosciences Geographic Atrophy Treatment Product
Table 61. Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 62. Hemera Biosciences Recent Development
Table 63. Allegro Ophthalmics Company Detail
Table 64. Allegro Ophthalmics Business Overview
Table 65. Allegro Ophthalmics Geographic Atrophy Treatment Product
Table 66. Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 67. Allegro Ophthalmics Recent Development
Table 68. Stealth BioTherapeutics Company Detail
Table 69. Stealth BioTherapeutics Business Overview
Table 70. Stealth BioTherapeutics Geographic Atrophy Treatment Product
Table 71. Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 72. Stealth BioTherapeutics Recent Development
Table 73. Gyroscope Therapeutics Company Detail
Table 74. Gyroscope Therapeutics Business Overview
Table 75. Gyroscope Therapeutics Geographic Atrophy Treatment Product
Table 76. Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 77. Gyroscope Therapeutics Recent Development
Table 78. Regenerative Patch Technologies Company Detail
Table 79. Regenerative Patch Technologies Business Overview
Table 80. Regenerative Patch Technologies Geographic Atrophy Treatment Product
Table 81. Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 82. Regenerative Patch Technologies Recent Development
Table 83. Roche Holding AG Company Detail
Table 84. Roche Holding AG Business Overview
Table 85. Roche Holding AG Geographic Atrophy Treatment Product
Table 86. Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 87. Roche Holding AG Recent Development
Table 88. Gensight Biologics SA Company Detail
Table 89. Gensight Biologics SA Business Overview
Table 90. Gensight Biologics SA Geographic Atrophy Treatment Product
Table 91. Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 92. Gensight Biologics SA Recent Development
Table 93. NGM Biopharmaceuticals Company Detail
Table 94. NGM Biopharmaceuticals Business Overview
Table 95. NGM Biopharmaceuticals Geographic Atrophy TreatmentProduct
Table 96. NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 97. NGM Biopharmaceuticals Recent Development
Table 98. AstraZeneca Company Detail
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Geographic Atrophy TreatmentProduct
Table 101. AstraZeneca Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 102. AstraZeneca Recent Development
Table 103. Lineage Cell Therapeutics Company Detail
Table 104. Lineage Cell Therapeutics Business Overview
Table 105. Lineage Cell Therapeutics Geographic Atrophy TreatmentProduct
Table 106. Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 107. Lineage Cell Therapeutics Recent Development
Table 108. Allergan Company Detail
Table 109. Allergan Business Overview
Table 110. Allergan Geographic Atrophy TreatmentProduct
Table 111. Allergan Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 112. Allergan Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Treatment Market Share by Type: 2021 VS 2028
Figure 2. Late-stage (Phase III) Treatment Features
Figure 3. Phase II Treatment Features
Figure 4. Phase I Treatment Features
Figure 5. Pre-Clinical Stage Treatment Features
Figure 6. Global Geographic Atrophy Treatment Market Share by Application in 2021 & 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Geographic Atrophy Treatment Report Years Considered
Figure 10. Global Geographic Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Geographic Atrophy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Geographic Atrophy Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Geographic Atrophy Treatment Market Share by Players in 2021
Figure 14. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2021
Figure 16. North America Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Geographic Atrophy Treatment Market Share by Country (2017-2028)
Figure 18. United States Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Geographic Atrophy Treatment Market Share by Country (2017-2028)
Figure 22. Germany Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Geographic Atrophy Treatment Market Share by Region (2017-2028)
Figure 30. China Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Geographic Atrophy Treatment Market Share by Country (2017-2028)
Figure 38. Mexico Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Geographic Atrophy Treatment Market Share by Country (2017-2028)
Figure 42. Turkey Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 45. IVERIC bio Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 46. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 47. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 48. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 49. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 50. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 51. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 52. Roche Holding AG Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 53. Gensight Biologics SA Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 54. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 55. AstraZeneca Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 56. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 57. Allergan Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
